AMICUS THERAPEUTICS INC (FOLD)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
2
Reporting holders
$11.5K
Reported value
0.0%
Held as options
-273
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $11.5K | 796 | 0.00% | 24q | -2.2% |
| HUNTINGTON NATIONAL BANK | $14 | 1 | 0.00% | 15q | HELD |
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-08-12 | 13G/A | THE GOLDMAN SACHS GROUP, INC.with 1 co-filers | 0.0% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2 | $11.5K | 797 | 0 | 0 | 1 | 0.0% |
| Q1 2026 | 275 | $4.6B | 316,689,927 | 38 | 98 | 85 | 0.3% |
| Q4 2025 | 308 | $4.6B | 317,004,374 | 81 | 98 | 84 | 0.9% |
| Q3 2025 | 269 | $2.5B | 313,932,415 | 46 | 96 | 82 | 0.7% |
| Q2 2025 | 254 | $1.8B | 320,266,554 | 32 | 113 | 74 | 0.2% |
| Q1 2025 | 266 | $2.5B | 311,811,490 | 35 | 99 | 80 | 0.3% |
| Q4 2024 | 271 | $2.9B | 302,967,149 | 24 | 95 | 89 | 0.3% |
| Q3 2024 | 269 | $3.4B | 320,132,625 | 51 | 79 | 82 | 0.4% |
| Q2 2024 | 239 | $3.3B | 327,296,192 | 33 | 90 | 66 | 0.2% |
| Q1 2024 | 232 | $4.2B | 353,302,976 | 40 | 80 | 66 | 0.3% |
| Q4 2023 | 210 | $4.9B | 347,582,554 | 20 | 87 | 50 | 0.5% |
| Q3 2023 | 205 | $3.6B | 295,645,665 | 22 | 74 | 62 | 0.5% |
| Q2 2023 | 195 | $3.7B | 301,648,441 | 21 | 67 | 66 | 0.3% |
| Q1 2023 | 192 | $3.2B | 287,577,267 | 25 | 75 | 46 | 0.3% |
| Q4 2022 | 182 | $3.1B | 254,238,706 | 23 | 74 | 46 | 0.5% |
| Q3 2022 | 223 | $3.2B | 307,277,233 | 34 | 72 | 71 | 0.4% |
| Q2 2022 | 213 | $3.3B | 305,211,574 | 28 | 65 | 74 | 0.5% |
| Q1 2022 | 215 | $2.9B | 303,462,128 | 22 | 57 | 83 | 0.2% |
| Q4 2021 | 225 | $3.8B | 328,557,997 | 19 | 71 | 78 | 0.4% |
| Q3 2021 | 237 | $2.8B | 292,762,510 | 27 | 78 | 78 | 1.2% |
| Q2 2021 | 236 | $2.9B | 300,064,623 | 32 | 81 | 71 | 0.9% |
| Q1 2021 | 256 | $2.8B | 276,407,292 | 43 | 96 | 76 | 1.7% |
| Q4 2020 | 278 | $6.6B | 279,392,638 | 47 | 82 | 96 | 2.6% |
| Q3 2020 | 249 | $4.0B | 278,256,583 | 41 | 73 | 91 | 1.3% |
| Q2 2020 | 228 | $4.3B | 282,536,527 | 44 | 71 | 69 | 1.1% |
| Q1 2020 | 202 | $2.7B | 288,413,818 | 29 | 60 | 70 | 0.7% |
| Q4 2019 | 221 | $2.7B | 280,130,595 | 39 | 85 | 57 | 0.6% |
| Q3 2019 | 206 | $2.3B | 279,300,908 | 37 | 79 | 48 | 0.5% |
| Q2 2019 | 207 | $3.4B | 271,546,576 | 40 | 87 | 37 | 1.0% |
| Q1 2019 | 209 | $3.5B | 257,539,186 | 37 | 75 | 52 | 1.0% |
| Q4 2018 | 193 | $2.2B | 233,659,890 | 5 | 3 | 4 | 0.6% |